Find a Tender
complete
Official procurement procedure
AVACOPAN (TAVNEOS) 10 mg Capsules;180 Capsule Pack
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Northern Health and Social Care Trust: "AVACOPAN (TAVNEOS) 10 mg Capsules;180 Capsule Pack". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Northern Health and Social Care Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Northern Health and Social Care Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Northern Health and Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationHigh Concentration
SCIENSUS PHARMA SERVICES LIMITEDTop vendor: 93% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 17 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| SCIENSUS PHARMA SERVICES LIMITED | 1 win | £4,000,000 |
| ALLOGA UK LIMITED | 1 win | £300,000 |
Procedure terms
Contracting AuthorityNorthern Health and Social Care Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 Jun 2026, 15:55 BST | Last source update2 Jun 2026, 15:55 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-069dbe | ||
What is being bought
Contract for supply of AVACOPAN (TAVNEOS) 10 mg Capsules to Northern Health and Social Care Trust for a period of up to 3 years
What changed
From the official release history
- Official notice release published
2 Jun 2026, 15:55 BST - Official notice release published
20 May 2026, 15:25 BST - Status changed to complete
20 May 2026, 15:15 BST - Official notice release published
20 May 2026, 15:15 BST - Buyer information updated
20 May 2026, 15:15 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 Jun 2026, 15:55 BST - Award active
Not published · Not published - Contract active
Signed 1 Jun 2026, 00:00 BST · £200,000
Commercial outcome and competition
Awards ALLOGA UK LIMITED Not published · Not published · active |
Contracts Contract £200,000 · signed 1 Jun 2026, 00:00 BST · active Contract period: 2 Jun 2026, 00:00 BST — 31 May 2029, 23:59 BST |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Northern Health and Social Care Trust
Contracting authority GB-PPON-PBRP-6676-CQZYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationalePurchase of drugs which are subject to patent protection/ Sole MA Holder, where no reasonable alternative or substitute exists.
Section 41 schedule 5 of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract -
(a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and
(b)there are no reasonable alternatives to those goods,services or works.
The product required is only commercially available from one supplier and no competition or alternative exists for this product.
The absence of competition is not the artificial narrowing of the parameters of the procurement. |